Page 1 of 1

RE ALEMTUZUMAB SEEN TOSLOW DISEASE PROGRSSION BY TARGETING

Posted: Fri Apr 01, 2016 12:16 am
by seeva
HI Friends please read
http://multiplesclerosisnewstoday.com/2 ... n-systems/
regards
seeva

Re: RE ALEMTUZUMAB SEEN TOSLOW DISEASE PROGRSSION BY TARGETI

Posted: Mon May 23, 2016 5:33 pm
by Bellalisimo
Is this available now

Re: RE ALEMTUZUMAB SEEN TOSLOW DISEASE PROGRSSION BY TARGETI

Posted: Mon May 23, 2016 6:07 pm
by euphoniaa
Bellalisimo wrote:Is this available now
There is a whole separate forum here with info and discussions about this med, brand name Lemtrada (formerly Campath).
http://www.thisisms.com/forum/campath-f12/

And here's a link to the Lemtrada website, with the most important safety warnings & information on the front page:
https://www.lemtrada.com/

FYI - On every drug's website you can find a link to their full "Prescribing Information" and also their "Medication Guide." Here's a link to Lemtrada's Prescribing Information: http://products.sanofi.us/lemtrada/lemtrada.pdf

Re: RE ALEMTUZUMAB SEEN TOSLOW DISEASE PROGRSSION BY TARGETI

Posted: Mon May 23, 2016 6:10 pm
by euphoniaa
I also found this quote at the top of the Lemtrada website:
LEMTRADA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS). Because of its risks, LEMTRADA is generally used in people who have tried 2 or more MS medicines that have not worked well enough. It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.